
BackTable Vascular & Interventional
Ep. 361 Intra-Arterial and Percutaneous Treatment of Giant Hepatic Hemangiomas with Dr. Jafar Golzarian
Sep 1, 2023
Dr. Jafar Golzarian, interventional radiologist at the University of Minnesota, discusses cutting edge treatments for giant hepatic hemangiomas, including transarterial bleomycin-lipiodol embolization and percutaneous injection. He focuses on treating hemangiomas that are large, cause pain or pressure on vital structures. The podcast also touches on the Global Embolization Symposium and Technologies initiative and the growth of the field.
38:53
Episode guests
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- Intra-arterial and percutaneous treatment of giant hepatic hemangiomas effectively reduces symptoms like pain and compression of nearby structures.
- The use of bleomycin and lipiodol mixture through either percutaneous or intra-arterial injection is a minimally invasive and successful treatment option for symptomatic hepatic hemangiomas, providing significant improvement and durable results without the need for retreatment.
Deep dives
Summary
In this podcast episode, Dr. Jeff Margolzerian discusses the intrarterial and percutaneous treatment of giant hepatic hemangiomas. He explains that these treatments are effective in reducing the symptoms caused by the hemangiomas, such as pain and compression of other structures. The treatment involves injecting a mixture of bleomycin and lipiodol directly into the lesion. Dr. Margolzerian discusses the success rates of the treatment and highlights the importance of patient selection, timing, and monitoring. He also emphasizes that this minimally invasive procedure offers a gratifying solution compared to surgical alternatives, providing significant improvement and avoiding the post-surgical complications associated with liver resection.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.